Merit Medical Systems, Inc.
Rank #274Op. LeverageMMSI · Nasdaq · Healthcare
Merit Medical Systems, Inc. (MMSI) — Rank #274 by gross profitability (GP/assets 0.26) · ROE 7.6% · Piotroski F-Score 7 / 9.
As-of 2026-09-15 · CIK 0000856982 · all metrics point-in-time as of the filing date.
About
Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures in the United States, China, Japan, Germany, France, the United Kingdom, and internationally.
Show moreShow less
It operates through two segments, Cardiovascular and Endoscopy. The company offers micropuncture kits, angiographic needles, sheaths, guide wires, and safety products; peripheral intervention products comprising angiography, drainage, delivery systems, and embolotherapy products; oncology products, such as soft tissue biopsy products and accessories; cardiac intervention products consisting of cardiac access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention products; and spine products, including vertebral augmentation, radiofrequency ablation, and bone biopsy systems. It also provides custom procedural solutions, including critical care products, syringes, manifold kits, and trays and packs; coating services for medical tubes and wires; and sensor components for microelectromechanical systems. In addition, the company offers gastroenterology products, such as esophageal stents, cryoballoon and inflation devices, gauges, and balloon dilators; pulmonary products consisting of laser-cut tracheobronchial stents, and over-the-wire and direct visualization delivery systems; and kits and accessories for endoscopy and bronchoscopy procedures. It sells its products to hospitals, alternate site-based physicians, technicians, and nurses through direct sales force, independent distributors, original equipment manufacturer partners, and custom procedure tray manufacturers. The company exports its products to Canada, Western Europe, Australia, Brazil, Malaysia, South Korea, the United Arab Emirates, India, New Zealand, and South Africa. Merit Medical Systems, Inc.
was incorporated in 1987 and is headquartered in South Jordan, Utah.
- Industry
- Medical Instruments & Supplies
- Sector
- Healthcare
- State
- UT
- Filer Category
- Large accelerated filer
- Fiscal Year End
- December 31
- Website
- merit.com
Financials
Each fiscal year is read as-of that year’s own 10-K filing, so nothing restated after the fact leaks backwards. Line items this filer never tagged are omitted. Hover or tap a badge for the diagnostic behind it.
| Fiscal year end | 2025-12-31filed 2026-02-24 | 2024-12-31filed 2025-02-25 | 2023-12-31filed 2024-02-28 | 2022-12-31filed 2023-02-24 |
|---|---|---|---|---|
| Revenue | 1,515.9 | 1,356.5 | 1,257.4 | 1,151.0 |
| Revenue growth (YoY) | 11.8% | 7.9% | 9.2% | 7.1% |
| Cost of revenue | 777.6 | 713.2 | 673.5 | 631.9 |
| Gross profit | 738.3 | 643.3 | 583.9 | 519.1 |
| Gross margin | 48.7% | 47.4% | 46.4% | 45.1% |
| Selling, general & administrative | 455.2 | 399.7 | 373.7 | 342.5 |
| Research & development | — | — | — | — |
| Operating income | 184.7 | 155.7 | 123.9 | 87.6 |
| Operating margin | 12.2% | 11.5% | 9.9% | 7.6% |
| Interest income | — | — | — | — |
| Interest expense | — | — | 15.5 | 6.3 |
| Pre-tax income | 170.9 | 150.0 | 112.1 | 82.6 |
| Income tax expense | 42.4 | 29.6 | 17.7 | 8.1 |
| Net income | 128.5 | 120.4 | 94.4 | 74.5 |
| Net margin | 8.5% | 8.9% | 7.5% | 6.5% |
| EPS (basic) | $2.17 | $2.07 | $1.64 | $1.31 |
| EPS (diluted) | $2.13 | $2.03 | $1.62 | $1.29 |
Figures are as originally filed with the SEC (point-in-time), not restated, so they can differ slightly from sites that show later-restated numbers. Why point-in-time?